NCT02211638View on ClinicalTrials.gov

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

CompletedOBSERVATIONAL
Enrollment

18,113

Participants

Timeline

Start Date

June 13, 2011

Primary Completion Date

April 25, 2013

Study Completion Date

April 25, 2013

Conditions
Hypertension
Interventions
DRUG

Candesartan Cilexetil

Candesartan Cilexetil tablet

Trial Locations (1)

Unknown

Osaka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02211638 - Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」 | Biotech Hunter | Biotech Hunter